-
Pharmaceutical grade methylparaben 500 g of methylparaben is available in batches
Time of Update: 2022-09-21
0ml of filtrate, check according to law (general 0801), and compare with the control solution made of standard sodium chloride solution of 7.
0ml of filtrate, check according to law (general 0801), and compare with the control solution made of standard sodium chloride solution of 7.
-
FDA grants priority review to futibatinib, FGFR inhibitor tripartite situation may be broken
Time of Update: 2022-04-27
In April 2021, futibatinib was granted Breakthrough Drug Designation by the FDA for the treatment of patients with previously treated locally advanced or metastatic cholangiocarcinoma harboring FGFR2 gene rearrangements .
-
"The Lancet" Sub-Journal: Molecular typing can guide the selection of treatment options for renal cell carcinoma; FGFR inhibitor pemitinib is approved in China for the treatment of cholangiocarcinoma
Time of Update: 2022-04-26
*Only for medical professionals to read and reference for 1 minute a day, to give you professional "talks" in the tumor circle! (If you need the original text, you can add Xiaobian WeChat yxj_oncolog
-
Arthritis Rheumatol: Oral uric acid-lowering drugs intensify uric acid-lowering treatment of erosive gout
Time of Update: 2022-01-07
immunityThe researchers conducted a two-year double-blind, randomized, controlled trial on 104 erosive gout participants who received oral uric acid-lowering therapy (ULT) and serum uric acid ≥ 0.
-
A stroke after waking up
Time of Update: 2021-05-22
Qualitative diagnosis: the patient is elderly male, with acute onset, past history of pulmonary heart disease, long-term smoking history, ECG monitoring after admission indicates atrial fibrillation, there are multiple high-risk factors for cerebrovascular disease, head CT excludes bleeding and space occupation, first consider acute Ischemic cerebrovascular disease-basilar artery tip syndrome (TOBS), the mechanism of cardiogenic embolism may be possible, and secondly, the possibility of infection, poisoning, metabolic disorder, etc.
-
FDA approves Zegalogue injection to treat diabetic patients with severe hypoglycemia
Time of Update: 2021-04-27
CompilationFan DongdongA few days ago, Zealand Pharma announced that the US FDA has approved Zegalogue (dasiglucagon) injection for the treatment of severe hypoglycemia in children and adult diabetic patients 6 years and older.
-
South Korea recalls natural flavor products that exceed the standard of beet ning and ethyl oxyfu grass yellow
Time of Update: 2020-12-08
Food Partners Network News July 1, South Korea's Ministry of Food and Drug Safety (MFDS) issued a message: South Korea's imported food sales enterprises Dolby Industry (Co., Ltd.) imports, food sub-packing enterprises Co., Ltd. sunny F2 sub-pack, sales of parsley flakes (food type: natural flavor) detected beet ning, ethyl oxycodroid yellow exceeded the standard, ordered it to stop selling and recall the product.
-
Keytruda has been approved for the first PD-1 treatment for NMIBC
Time of Update: 2020-08-01
On January 8, local time, the U.S. FDA announced the approval of Mercato's PD-1 inhibitor Keytruda (pembrolizumab) as a single drug therapy for specific high-risk non-muscle-immersed bladder cancer (NMIBC) patients, specifically: non-qualified bladder removal or have chosen not to have a bladder removal of the catonic seedlings without response, high risk, associated with insituated cancer (CIS), companion or non-cosmic nipple lesions.
-
JCEM: The Effects of Dinner Time on Healthy People's Metabolism
Time of Update: 2020-06-25
Calorie consumption at night is associated with obesity and metabolic syndrome In a recent study published in the journal Journal of Endocrine and Metabolic Diseases, researchers hypothesized that l